Grup Moehs
Referent a nivell mundial
En un mercat de ràpid creixement i alta competitivitat, el Grup MOEHS ha progressat convertint-se en un dels actors principals a nivell mundial.
ELS FACTORS CLAU QUE CONFIRMEN AQUESTA TRAJECTÒRIA SÓN:
Consolidació d'una àmplia gamma de productes amb diferents activitats terapèutiques: des de mucolitics fins a ß-blocants.
Ampliació contínua de la nostra llista de APIs.
Òptim equilibri entre costos i serveis oferts.
Capacitat de comprensió de les necessitats transmeses pels clients per a traslladar-les a la nostra gamma.
Suport documental i regulador.
Llista de Productes
Nom del producte | Cas nº | Categoria terapèutica | Dades Reglamentàries | Farmacopees | Planta de producció |
---|---|---|---|---|---|
ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | In house | BCN |
CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
LANSOPRAZOLE | 103577-45-3 | Antiulcerative | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, JDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & M. BCN |
LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
MAGNESIUM LACTATE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur., BP 2013 | BENECHIM |
MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
OLMESARTAN | 144689-63-4 | Antihypertensive | EDMF | Ph. Eur. 11 | M. CATALANA |
PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
TELMISARTAN | 144701-48-4 | Antihypertensive | EDMF, USDMF, CEP | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
TRIAMTERENE | 396-01-0 | Diuretic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
TRIMEBUTINE BASE | 39133-31-8 | Antispasmodic | EDMF | in house | CANTABRA |
TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
Productos en fase final de desarrollo
Nom del producte | Cas nº | Categoria terapèutica | Dades Reglamentàries | Farmacopees | Planta de producció |
---|---|---|---|---|---|
ACEBUTOLOL HCL | 34381-68-5 | Antianginal – Antihypertensive – Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CANTABRA & COPRIMA |
AMANTADINE HCl | 665-66-7 | Antiviral -Antiparkinsonian | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
AMANTADINE SULPHATE | 31377-23-8 | Antiviral -Antiparkinsonian | EDMF | DAC 2011 | CANTABRA |
AMLODIPINE BESILATE | 111470-99-6 | Antianginal – Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
ARTICAINE HCI or CARTICAINE HCI | 23964-57-0 | Local Anesthetic- Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
BISOPROLOL FUMARATE | 104344-23-2 | Antihypertensive | CEP, EDMF, USDMF, JDMF, ND | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | Local Anesthetic Antiarrhythmic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
CARBOCYSTEINE | 638-23-3 | Mucolytic | CEP, EDMF, JDMF | Ph. Eur. 11, JP 16 | M. CATALANA & M. BCN |
CARBOCYSTEINE LYSINE SALT | 151756-26-2 | Mucolytic | EDMF | In house | BCN |
CARVEDILOL | 72956-09-3 | Antihypertensive | CEP, EDMF, USDMF, JDMF, KDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & COPRIMA |
CELIPROLOL HCI | 57470-78-7 | Antianginal- Antihypertensive | CEP, EDMF, JDMF | Ph. Eur. 11 | COPRIMA |
CHOLINE FENOFIBRATE | 856676-23-8 | Antihyperlipidemic | USDMF | In house | COPRIMA |
DEXMEDETOMIDINE HCL | 145108-58-3 | Sedative | DMF | USP-NF-2022 | NORCHIM & IBERICA |
DULOXETINE HCL | 136434-34-9 | Antidepressant | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA & M. BCN |
FENOFIBRATE | 49562-28-9 | Antihyperlipidemic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | COPRIMA |
LANSOPRAZOLE | 103577-45-3 | Antiulcerative | CEP, EDMF, USDMF, JDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
LIDOCAINE BASE | 137-58-06 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, JDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & M. BCN |
LIDOCAINE HCI | 6108-05-0 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA & M. BCN |
MAGNESIUM LACTATE DIHYDRATE | 18917-93-6 | Magnesium Supplement | EDMF, ND | Ph. Eur. 11 | CANTABRA |
MEBEVERINE HCl | 2753-45-9 | Antispasmodic | EDMF, ND | Ph. Eur., BP 2013 | BENECHIM |
MEPIVACAINE HYDROCHLORIDE | 1722-62-9 | Local Anesthetic-Antiarrhythmic | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
METOPROLOL SUCCINATE | 98418-47-4 | Antihypertensive | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
METOPROLOL TARTRATE | 56392-17-7 | Antihypertensive | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | M. CATALANA |
N-ACETYLCYSTEINE | 616-91-1 | Mucolytic | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
NIFEDIPINE | 21829-25-4 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
NIFUROXAZIDE | 965-52-6 | Antidiarrheal | EDMF, ND | Ph. Eur. 11 | COPRIMA |
OLMESARTAN | 144689-63-4 | Antihypertensive | EDMF | Ph. Eur. 11 | M. CATALANA |
PANTOPRAZOLE SODIUM | 164579-32-2 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
PRILOCAINE BASE | 721-50-6 | Local Anesthetic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
PRILOCAINE HCL | 1786-81-8 | Local Anesthetic-Antiarrhythmic | EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
PYRANTEL EMBONATE | 22204-24-6 | Anthelmintic | EVMF, USVMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA & COPRIMA |
QUETIAPINE FUMARATE | 111974-72-2 | Antipsychotic | CEP, EDMF, USDMF, KDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
RABEPRAZOLE SODIUM | 117976-90-6 | Antiulcerative | CEP, EDMF, USDMF, ND | Ph. Eur. 11 | M. CATALANA |
ROPIVACAINE HCL | 132112-35-7 | Local Anesthetic | USDMF | Ph. Eur. 11, USP-NF-2022 | BENECHIM |
SITAGLIPTIN HCL | 862156-92-1 | Antidiabetic | EDMF | in house | BENECHIM |
SOTALOL HCL | 959-24-0 | Antianginal-Antihypertensive | CEP, EDMF, USDMF, ND | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
SUMATRIPTAN BASE | 103628-46-2 | Antimigraine | USDMF | USP-NF-2022 | M. CATALANA |
SUMATRIPTAN SUCCINATE | 103628-48-4 | Antimigraine | EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
TELMISARTAN | 144701-48-4 | Antihypertensive | EDMF, USDMF, CEP | Ph. Eur. 11, USP-NF-2022 | M. CATALANA |
TRIAMTERENE | 396-01-0 | Diuretic | CEP, EDMF, USDMF, JDMF | Ph. Eur. 11, USP-NF-2022, JP 16 | M. CATALANA |
TRIMEBUTINE BASE | 39133-31-8 | Antispasmodic | EDMF | in house | CANTABRA |
TRIMEBUTINE MALEATE | 34140-59-5 | Antispasmodic | CEP, EDMF, ND | Ph. Eur. 11, JP 16 | M. CATALANA & M. CANTABRA |
VENLAFAXINE HCI | 99300-78-4 | Antidepressant | CEP, EDMF, USDMF | Ph. Eur. 11, USP-NF-2022 | M. CANTABRA |
VILDAGLIPTIN | 274901-16-5 | Antidiabetic | DMF | Ph. Eur. 11 | BCN |
Nombre del producto | CAS N° | Categoría terapéutica | Disponibilidad | Datos regulatorios | Farmacopea |
---|---|---|---|---|---|
EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF | |
EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF | |
LEVOBUPIVACAINE HCL (**) | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | TP | |
REMIMAZOLAM (**) | 308242-62-8 | Sedative | Laboratory batches | US-DMF | |
RIVAROXABAN (**) | 366789-02-8 | Antibleeding agent | Validation batches | DMF | Ph. Eur. |
SITAGLIPTIN HCL (**) | 862156-92-1 | Antidiabetic | Validation batches | DMF | |
SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF | USP / Ph. Eur. |
VILDAGLIPTIN (**) | 274901-16-5 | Antidiabetic | Validation batches | DMF |
(**) Moehs està treballant amb aquest compost amb finalitats experimentals, exclusivament dirigides a l’obtenció d’autoritzacions de comercialització dels medicaments genèrics dels nostres clients. No pretenem realitzar cap activitat contra cap protecció de patent vàlida, així com tampoc ens farem càrrec de les accions de tercers realitzades amb el compost proporcionat i sense el nostre coneixement contra aquesta protecció.
Productos en etapa inicial de desarrollo
Product Name | CAS N° | Therapeutic Category | Additional Information | DMF / TP |
---|---|---|---|---|
ABROCITINIB (**) | 1622902-68-4 | Atopic Dermatitis | Laboratory batches | TP |
DARIDOREXANT (**) | 1792993-84-0 | Insomnia | Laboratory batches | |
EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF |
ELAGOLIX (**) | 832720-36-2 | Uterine Fibroids, Endometriosis pain | Validation batches | TP |
EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF |
LASMIDITAN SUCCINATE (**) | 439239-92-6 | Antimigraine | Kilo - Lab batches | DMF |
LEMBOREXANT (**) | 1369764-02-2 | Insomnia treatment | Laboratory batches | TP |
LINZAGOLIX(**) | 935283-04-8 | Uterine Fibroids. Endometriosis | Laboratory batches | |
LEVOBUPIVACAINE HCL | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | DMF |
MAVACAMTEN (**) | 1642288-47-8 | Hypertrophic Cardiomyopathy | Kilo-lab batches | DMF |
NORADRENALINE TARTRARE | 636-88-4 | Cardiovascular | Kilo - lab batches | TP |
OBETICHOLIC ACID (**) | 459789-99-2 | Liver and gastrointestinal disorders | Validation batches | TP |
PATIROMER CALCIUM SORBITEX (**) | 1260645-52-4 | Hyperkalemia | Validation batches | TP |
RELUGOLIX (**) | 737789-87-6 | Advanced prostate cancer. Uterine Fibroids, endometriosis | Kilo-lab batches | DMF |
REMIMAZOLAM BESYLATE (**) | 308242-62-8 | Sedation General Aneshhesia | Validation batches | US-DMF |
RIMEGEPANT SULFATE (**) | 1374024-48-2 | Acute migraine | Kilo - lab batches | DMF |
TAPINAROF (**) | 115781-08-3 | Psoriasis | Laboratory batches | |
RIVAROXABAN (**) | 366789-02-8 | Oral anticoagulant | Validation batches | DMF |
SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF |
TIRBANIBULIN (**) | 897016-82-9 | Actinic Keratosis | Kilo - Lab batches | DMF |
VERICIGUAT (**) | 1350653-20-1 | Heart Failure | Kilo - lab batches | DMF |
Nuevos Productos en evaluación
Product Name | CAS N° | Brand Name | Therapeutic Category | Galenic Form |
---|---|---|---|---|
MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | capsules | |
VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | tablets |